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NEGLECTED DISEASES AND INNOVATION IN SOUTH ASIA
Neonatal sepsis in South Asia: huge burden and 
spiralling antimicrobial resistance
M Jeeva Sankar and colleagues call for urgent action to improve quality of care at birth and 
implement antimicrobial stewardship in health facilities in South Asia to reduce neonatal deaths 
from sepsis
Neonatal sepsis, a systemic infection in the first 28 days of life, encompasses blood-stream infections, meningitis, and pneumonia. It is the third 
most common cause of deaths among neo-
nates, accounting for 225 000 deaths glob-
ally every year.1
South Asia and sub-Saharan Africa have 
the highest burden of neonatal sepsis in the 
world. Of the total sepsis related neonatal 
deaths in 2013, 38.9% occurred in South 
Asia.1 2 Poverty, low coverage of effective 
interventions, including facility births, and 
gross inequities in delivery of healthcare3 
contribute to this situation. We review 
the available literature (box 1) to draw 
attention to the burden of neonatal sepsis, 
the pathogen profile, and the extent of 
antimicrobial resistance in South Asia, and 
propose priority actions for policymakers 
and health professionals in the region.
Paucity of high quality data
We found no data on neonatal sepsis from 
Afghanistan, Bhutan, Maldives, and little 
from Sri Lanka. While the neonatal health 
indicators of three of these four countries 
are reasonably good,3 the paucity of data 
from war torn Afghanistan is a cause for 
concern.
More importantly, the data from the 
four countries with the highest burden of 
neonatal sepsis (India, Pakistan, Nepal, 
and Bangladesh) are of poor quality. 
With the exception of studies such as 
the Young Infant Study4 ANISA,5 and the 
multisite study from the Delhi Neonatal 
Infections Study7 collaboration, most 
studies are retrospective, lack rigorous 
methods and standard definitions, and 
have used passive surveillance to identify 
cases. There is therefore an inherent risk 
of underestimating the burden of sepsis in 
the region.
High incidence of sepsis
The pooled incidence of culture posi-
tive sepsis in hospital based reports from 
South Asia is 15.8 per 1000 live births 
(95% CI 12.7 to 18.8, n=15 reports). This 
is about twofold to fourfold higher than that 
reported in high income countries such as 
England and the United States.89 The inci-
dence does not seem to have declined in 
the last decade.10 About a third of neonates 
with culture positive sepsis died as a result 
(median case fatality rate 34.4%). Table 1 
presents incidence and case fatality rates 
by country.
Sepsis is categorised into early onset 
sepsis (onset within 72 hours of birth) 
and late onset sepsis (beyond 72 hours). 
Early onset sepsis is thought to be caused 
by pathogens vertically transmitted from 
mothers while late onset sepsis is attributed 
to pathogens acquired horizontally from the 
environment or care givers, or both. About 
62% of the infections in South Asia occur in 
the first 72 hours of life, roughly translating 
into an incidence of 9.8 per 1000 live births. 
This is 10-fold higher than the incidence 
of early onset sepsis reported in a large 
nationwide study in the United States.9
Neonatal sepsis is classified as culture 
positive or culture negative, depending on 
KEY MESSAGES
•   The incidence of neonatal sepsis in 
South Asia is 4 to 10 times higher 
than that in developed countries
•   Unlike high income countries with 
a predominance of group B strep-
tococci, Gram negative organisms 
predominate, possibly indicating 
horizontal transmission of infections 
from the environment and healthcare 
providers
•   About 50-88% of common isolates 
from the health facilities are resistant 
to first line antibiotics—ampicillin and 
gentamicin
•   Simple, evidence based interventions 
can help, such as better asepsis, hand 
hygiene, and exclusive breastfeeding 
and establishing antimicrobial stew-
ardship programmes
Box 1 Sources and methods
We searched PubMed and Web of Science for literature published between January 2000 and 
August 2018 using the search terms: (newborn OR neonate) AND (sepsis OR infection OR 
antibiotic OR antimicrobial). The results were filtered for South Asian countries. Bibliographies 
of full text articles and published systematic reviews were also searched to identify additional 
articles.
We identified 2699 and 220 articles from PubMed and Web of Science, respectively, and 19 
additional articles from reference lists of identified articles. After removing duplicates, we 
screened 2768 articles and reviewed 223 full text articles. Finally, 109 studies were included: 
69 from India, 16 from Pakistan, 7 from Bangladesh, 14 from Nepal, 1 from Sri Lanka, and 
2 multi-country studies (Young Infant Study4 and Aetiology of Neonatal Infections in South 
Asia (ANISA)5) covering Bangladesh, India, and Pakistan). Because the datasets belonging to 
different time periods and/or different patient populations in a given study were considered 
unique, we had a total of 123 datasets from 109 studies.
Two authors (SS and SC) extracted information from the relevant studies. Most studies were 
hospital based, single centre studies that reported data on neonates with suspected sepsis 
or laboratory based studies reporting bacteriological profile and antimicrobial resistance 
of cultures received from neonatal intensive care units. We identified only eight relevant 
community based studies. Random effects meta-analysis was done to pool the results, if 
applicable, using the “metan” command in Stata 15.1 (StataCorp, College Station, TX). Pooling 
of rates was done separately for the hospital based and community based studies. See 
appendix on bmj.com for details of the methods and studies included.
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isolation of pathogen(s) from blood or other 
sterile fluids. Based on the available data, 
this review focuses on the burden of culture 
positive sepsis, which forms only part of the 
total number of sepsis cases. Because of the 
difficulty in obtaining an adequate volume 
of blood in preterm neonates and the low 
levels of bacteraemia, blood cultures tend 
to be sterile in many neonates. The culture 
positive versus culture negative sepsis ratio 
ranges from 1:6 to 1:16 in high income 
countries.11 The ratio is likely to be more 
skewed towards culture negative sepsis in 
South Asia, given the poor microbiological 
laboratory support in most units. The 
burden of total neonatal sepsis is therefore 
likely to be much higher.
The proportion of neonates with culture 
positive sepsis in community based studies 
was lower—12.3 per 1000 live births 
(95% CI 8.4 to 16.2). However, this was 
influenced by the ANISA study5 which 
used a statistical model incorporating the 
results of molecular assays to estimate 
the incidence of bacterial sepsis. If only 
conventional blood culture positive results 
are included, the pooled risk of sepsis was 
much lower—5.5 per 1000 live births (95% 
CI 2.4 to 8.6).
Unique pathogen profile
The pathogen profile in South Asia is differ-
ent from that found in high income coun-
tries. There is a predominance of Gram 
negative pathogens (>60%) and a low 
prevalence of group B streptococci in South 
Asia, compared with a high incidence of 
group B streptococci in high income coun-
tries.7 10
Among isolates from hospital settings 
(n=24 273), Gram negative organisms 
(63%) were the most common, with 
Klebsiella spp (23%), Escherichia coli 
(14%), and Acinetobacter spp (8%) being 
the top three. The most common Gram 
positive organisms were Staphylococcus 
aureus (20%) and Coagulase negative 
Staphylococci  (9%). Gram negative 
organisms were associated with higher case 
fatality (pooled proportion 26.7%; 95% CI 
0 to 41%) than Gram positive organisms 
(11.9%; 95% CI 10.5 to 13.3%). Among 
the 703 isolates from community settings, 
Klebsiella spp (25%), E coli (15%), and S 
aureus (12%) were the most common.
The predominance of Gram negative 
pathogens in South Asia suggests that the 
transition from Gram negative pathogens 
to Gram positive organisms such as group 
B streptococci that happened five to six 
decades ago in developed countries10—
largely because of improved aseptic 
routines, including hand hygiene in 
neonatal intensive care units—is yet to take 
place in South Asia.
There was a striking similarity between 
the pathogen profile of early onset and late 
onset sepsis (see supplementary fig 2 on 
bmj.com). This challenges the assumption 
of attributing early onset sepsis to vertical 
transmission from the mothers. Although 
it is possible that the pregnant women in 
South Asia are colonised with pathogens 
normally found in the hospitals (such as 
Klebsiella), it is more probable that the 
source of infection in early onset sepsis 
is the unhygienic practices in the labour 
rooms and neonatal intensive care units. 
Identifying the source and transmission 
pathways of common pathogens of early 
Table 1 | Incidence, case fatality rates, and infecting organism for neonatal sepsis in hospital based studies
India Pakistan Bangladesh Nepal Sri Lanka Total
No of studies (No of isolates) 64 (18 761) 16 (3557) 6 (584) 14 (1325) 1 (9) 101* (24 244)
Incidence (95% CI) of culture  positive 
sepsis, per 1000 live births; No of 
studies
16 (12.8 to 19.2); 
n=14
NA NA 11.6 (18.4 to 14.7); 
n=1
13.6/1000 patient 
days; n=1
15.7 (12.7 to 18.8); 
n=15
Case fatality rate (95% CI); No of 
studies
34.4 (33 to 35.7); 
n=14
30.9 (25.7 to 
36.2); n=2
19.1 (11.7 to 26.5); 
n=2
64.7 (54.3 to 75); 
n=1
NA 34.4(33.1 to 35.6); 
n=19
% Infecting organism (95% CI); No of 
studies
Klebsiella spp† 53.6 (50.7 to 56.5); 
n=21
NA NA 33 (3.0 to 63.0); 
n=1
60 53.3 (50.4-56.2); 
n=22
Escherichia coli† 42.2 (38.5 to 46); 
n=16
NA NA 50 (1.0 to 98.0); 
n=1
NA 42.2 (38.6 to 46.2); 
n=17
Meticillin resistant Staphylococcus 
aureus
43.2 (39.9 to 46.5); 
n=17
61 (49.1-72.8); 
n=1
NA 26 (12.8 to 39.3); 
n=3
NA 46.5 (41.9 to 51.1) 
n=21
Data represent pooled proportions (95% CI), unless stated otherwise. NA= not available
*Community based studies (n=8) are not included in table.
†Extended spectrum β lactamase.
Table 2 | Pathogen specific antimicrobial resistance in isolates from babies with neonatal sepsis in South Asia
Pathogen (total No of 
isolates)
% of isolates resistant (95% CI); No of isolates
Ampicillin Gentamicin Cefotaxime Ceftazidime Meropenem/ meticillin Multidrug
Hospital settings
Klebsiella spp (n=4312) 86.8 (85.8 to 87.3); 
2806
75.3 (74 to 76.7); 
2954
72.5 (71.3 to 73.7); 
4126
74.5 (73 to 75.9); 
2455
10.4 (9.4 to 11.5); 2540 70.7 (66.1 to 75.3)
E coli (n=2798) 88.2 (87 to 89.5); 
2196
67.9 (66 to 69.8); 
2254
66.9 (65.3 to 68.6); 
2745
69.4 (67.4 to 71.4); 
1773
8.1 (6.8 to 9.4); 1551 54.0 (48.1 to 59.9)
Acinetobacter spp 
(n=1347)
86.2 (83.8 to 88.5); 
633
68.1 (65.1 to 71); 
792
80.3 (78.2 to 82.4); 
1121
73.6 (70.8 to 76.3); 
718
64.8 (62.2 to 67.4); 828 78.7 (73.9 to 83.4)
S aureus (n=2437) 69 (67.3 to 70.6); 
2266
54.5 (52.4 to 56.6); 
1773
51.2 (49 to 53.3);1753 NA 46.5 (41.9 to 51.1); 310 NA
Community settings
Klebsiella spp (n=116) 87.9 (82.3 to 93.5) 22.8 (15 to 30.1) 25.7 (18 to 33.5) 28.5 (19.8 to 37.1) 0 (0 to 2) —
E coli (n=37) 72.4 (58 to 86) 18.7 (6 to 31) 50.3 (35 to 65.7) 37 (13.3 to 60.6) 0 (0 to 2) —
S aureus (n=77) 74.6 (66.6 to 82.6) 3 (0-9) 9 (2 to 16) NA 10 (0 to 20.5) —
Data represent pooled proportion (95% CI); n=number of isolates tested, unless stated otherwise.
NA=not applicable.
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onset sepsis is essential to determine the 
appropriate steps to prevent infection 
that will help to reduce the high burden of 
mortality associated with early onset sepsis 
in the region.
Spiralling antimicrobial resistance
Antimicrobial resistance has worsened in 
the last decade, rendering most antibiot-
ics obsolete. Resistance to even “reserve” 
antibiotics has increased—50-70% of the 
common Gram negative isolates are now 
multidrug resistant. Table 2 presents anti-
microbial resistance patterns found in com-
mon pathogens in hospital and community 
settings in South Asia.
The common pathogens from hospital 
based studies uniformly exhibit a high 
degree of resistance to first line drugs 
recommended by the World Health 
Organization—namely, ampicill in, 
gentamicin,  and third generation 
cephalosporins such as cefotaxime 
(table 2).6 However, most were susceptible 
to WHO classified “watch group”6 
antibiotics, such as meropenem (see suppl 
table 1 on bmj.com). About half (pooled 
proportion 46.5%; 95% CI 41.9 to 51.1) of 
S aureus isolates were meticillin resistant, 
but most remained susceptible to watch 
group antibiotics such as vancomycin. 
The varied pathogens with high resistance 
patterns preclude the use of intrapartum 
antibiotic prophylaxis to prevent vertically 
transmitted infection. In contrast, the 
antimicrobial resistance profile in the 
community based studies was not so high: 
although resistance to ampicillin was 
high, resistance to gentamicin and third 
generation cephalosporins was low.
I f  t h e  a p p a r e n t  d i c h o t o my  i n 
antimicrobial resistance between the 
hospital based and community based 
studies is real, health facilities in the 
region should review their antibiotic policy 
to prevent misuse of antibiotics. The high 
antimicrobial resistance brings into focus 
the overuse of antibiotics in neonates with 
culture negative sepsis. The ANISA study 
showed that many neonates with negative 
blood cultures had viral infections.5 The 
low case fatality in neonates with culture 
negative sepsis (only one fifth of that of 
culture positive sepsis) in the multisite 
study from Delhi7 also suggests that many 
of these neonates either had viral infections 
or did not have sepsis at all. More reliable 
and accurate point-of-care diagnostic 
method(s) are needed to rule out sepsis, 
thereby preventing indiscriminate use of 
antibiotics in neonatal intensive care units.
The low antimicrobial resistance in the 
community allows healthcare providers 
in primary and even secondary level 
facilities to use first line antibiotics in 
neonates with sepsis. Steps to prevent 
misuse of antibiotics in other sectors such 
as agriculture and restriction of over-the-
counter antibiotics15 16 would ensure that 
the antimicrobial resistance rates remain 
low in community settings.
Next steps
Surveillance and research
We need reliable data to track progress 
on neonatal sepsis in the region to enable 
benchmarking and cross-learning and 
inform policy making. A regional sur-
veillance database—possibly under the 
umbrella of the South Asian Association 
for Regional Cooperation—could provide 
such a mechanism, alongside surveillance 
databases within each country. This could 
begin with passive surveillance using uni-
form definitions and be followed up by 
active surveillance. Box 2 lists the major 
research priorities in the region.
Quality of care and antimicrobial stewardship 
in hospitals
Most health facilities in the region continue 
to be the “hot beds” of infection transmis-
sion in sick and vulnerable neonates.10 
Lack of essential equipment and supplies 
including soap, sinks, running water, and 
Team
• Neonatologist
• Microbiologist
• Senior nursing officer
• Statistician/public health expert
Strategies
• Scale up infection control practices
• Improve microbiology lab capacity (automated cultures)
• Standard operating procedures:
     Obtain blood culture before first dose of antibiotics
     When to screen and when to treat for sepsis
• Unit protocol:
     Antibiotic policy based on culture reports of last 6-12 months
     Stop or de-escalate to narrow spectrum antibiotics based on culture
       report
• Prior authorisation from antimicrobial stewardship programme team for
       “reserve” antibiotics
Audit and feedback
• Measure: proportion
     In whom cultures obtained before start of antibiotics
     Receiving “reserve” antibiotics
     Receiving right drug, right dose, and right duration
     Not receiving antibiotics in sick newborn care unit
• Measure: days of therapy (DOT) of common antibiotics
• Prospective audit and feedback to staff
Fig 1 | Proposed model of antimicrobial stewardship programme for health facilities in South 
Asia. Adapted from Ramasethu 2017; Patel 2012; Cantey 2014
Box 2 Research priorities for neonatal sepsis in South Asia
• Establish a subnational/national surveillance database to evaluate and monitor the burden of 
neonatal sepsis, sepsis related mortality, and antimicrobial resistance
• Implementation research—quality improvement initiatives—to scale up the coverage of 
known interventions
• Identify the source of infection and transmission pathways of common pathogens
• Evaluate the impact of introducing antimicrobial stewardship programmes at different levels 
of health facilities
• Develop and validate point-of-care diagnostic method(s) for rapid and accurate diagnosis of 
sepsis
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disposables; overcrowding and understaff-
ing; and suboptimal disinfection practices 
increase the risk of horizontal transmis-
sion of infections from the labour rooms 
or neonatal intensive care unit.10 The two-
fold greater risk of sepsis in hospital based 
studies compared with community based 
studies suggests that horizontal trans-
mission—that is, healthcare associated 
infections—plays a major part in the high 
incidence of neonatal sepsis in the region. 
Selective referral of high risk neonates to 
hospitals may also account for this. With 
increasing rates of facility births, the bur-
den of neonatal sepsis is bound to increase 
unless radical measures to improve the 
quality of care are implemented.
Antimicrobial stewardship programmes 
must be implemented to rationalise 
antibiotic use. Policy makers and other 
stakeholders should develop guidelines 
and toolkits to facilitate implementation of 
these programmes across health facilities 
at different levels of the health system. 
Steps should be simplified and continuous 
monitoring and auditing done to inform 
healthcare providers of the progress made. 
Figure 1 depicts a simplified model of 
antimicrobial stewardship programmes 
for use in health facilities in the region.12-14
Scale up effective interventions
The Every Newborn series on quality of 
care at birth identified that scaling up of 
evidence based interventions could reduce 
infection related neonatal deaths by 84% 
globally.17 This is likely to have a major 
impact in South Asian countries3 because 
the existing coverage of these interven-
tions in almost all countries is low, except 
in Maldives and Sri Lanka. For example, the 
proportion of pregnant women receiving at 
least four antenatal visits in Afghanistan 
(18%), Bangladesh (31%), India (51%), 
Nepal (69%), and Pakistan (37%) is low. 
The proportion of births attended by skilled 
health workers is 51%, 42%, 81%, 58%, 
and 55%, respectively.18 The median cover-
age of clean birth practices is 33.9%,3 and 
of the first postnatal check-up in the first 
two days of birth is 31% in all countries 
except Maldives and Sri Lanka.18Figure 2 
lists key interventions that could reduce 
the high burden of sepsis, sepsis related 
mortality, and antimicrobial resistance.
Concerted efforts at national and regional 
levels to identify health system related 
issues resulting in high incidence of sepsis 
and antimicrobial resistance, to improve 
the coverage of known interventions, and 
to implement context specific solutions that 
are simple and effective, along with a strong 
political will, will go a long way to reduce 
the burden of sepsis related mortality and 
morbidity in the region.
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